- Home
- IMOS vs VALN Comparison
IMOS vs VALN Comparison
Compare IMOS & VALN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMOS
- VALN
- Stock Information
- Founded
- IMOS 1997
- VALN 2012
- Country
- IMOS Taiwan
- VALN France
- Employees
- IMOS N/A
- VALN N/A
- Industry
- IMOS Semiconductors
- VALN Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- IMOS Technology
- VALN Health Care
- Exchange
- IMOS Nasdaq
- VALN Nasdaq
- Market Cap
- IMOS 551.9M
- VALN 510.7M
- IPO Year
- IMOS N/A
- VALN 2021
- Fundamental
- Price
- IMOS $18.79
- VALN $6.39
- Analyst Decision
- IMOS
- VALN Strong Buy
- Analyst Count
- IMOS 0
- VALN 3
- Target Price
- IMOS N/A
- VALN $15.33
- AVG Volume (30 Days)
- IMOS 33.7K
- VALN 12.7K
- Earning Date
- IMOS 05-13-2025
- VALN 05-07-2025
- Dividend Yield
- IMOS 6.08%
- VALN N/A
- EPS Growth
- IMOS N/A
- VALN N/A
- EPS
- IMOS 0.06
- VALN N/A
- Revenue
- IMOS $692,370,614.00
- VALN $201,099,222.00
- Revenue This Year
- IMOS N/A
- VALN $17.98
- Revenue Next Year
- IMOS $2.21
- VALN $26.61
- P/E Ratio
- IMOS $14.85
- VALN N/A
- Revenue Growth
- IMOS 6.27
- VALN 21.64
- 52 Week Low
- IMOS $12.78
- VALN $3.62
- 52 Week High
- IMOS $28.34
- VALN $9.50
- Technical
- Relative Strength Index (RSI)
- IMOS 62.33
- VALN 44.86
- Support Level
- IMOS $17.03
- VALN $6.18
- Resistance Level
- IMOS $18.79
- VALN $6.55
- Average True Range (ATR)
- IMOS 0.68
- VALN 0.30
- MACD
- IMOS 0.23
- VALN -0.02
- Stochastic Oscillator
- IMOS 83.05
- VALN 19.37
About IMOS ChipMOS TECHNOLOGIES INC.
ChipMOS TECHNOLOGIES Inc is engaged in the research, development, manufacturing, and sale of high-integration and high-precision integrated circuits and related assembly and testing services. The company's segments include Testing, Assembly, Testing, and Assembly for LCD, OLED, and other Display Panel Driver Semiconductors (LCDD), Bumping, and others. It derives a majority of its revenue from Taiwan followed by Japan, the People's Republic of China, Singapore, and others.
About VALN Valneva SE
Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.